Related Experiment Videos
All trans retinoic acid enhances human LAK activity
C Fegan1, R Bailey-Wood, S Coleman
1Department of Haematology, University of Wales College of Medicine, Cardiff.
European Journal of Haematology
|February 1, 1995
Summary
All trans retinoic acid boosts immune cell activity. This vitamin A derivative enhances lymphokine-activated killer (LAK) cell function by increasing key cytokine production and receptor expression.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- All trans retinoic acid (ATRA) influences normal and malignant cell functions.
- Lymphokine-activated killer (LAK) cells, derived from T lymphocytes and natural killer cells, are crucial for immune responses.
- Understanding ATRA's impact on immune cells is vital for therapeutic development.
Purpose of the Study:
- To investigate the effect of all trans retinoic acid on lymphokine-activated killer (LAK) activity.
- To elucidate the mechanisms by which ATRA modulates immune cell function.
Main Methods:
- Treatment of immune cells with varying concentrations of all trans retinoic acid.
- Assessment of LAK activity.
- Measurement of cytokine production (tumor necrosis factor and gamma interferon).
- Analysis of interleukin 2 receptor p55 subunit expression.
Main Results:
- All trans retinoic acid significantly enhanced LAK activity.
- ATRA increased the production of tumor necrosis factor and gamma interferon.
- Enhanced expression of the p55 subunit of the interleukin 2 receptor was observed.
- The observed effects were dose-dependent and time-dependent.
Conclusions:
- All trans retinoic acid potentiates LAK cell-mediated immune responses.
- ATRA's mechanism involves increased cytokine production and enhanced IL-2 receptor expression.
- These findings suggest potential therapeutic applications for ATRA in immunotherapy.